Skip to main content
Log in

Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Cellulitis, an infection involving the deep dermis and subcutaneous tissue, is the most common reason for skin-related hospitalization and is seen by clinicians across various disciplines in the inpatient, outpatient, and emergency room settings, but it can present as a diagnostic and therapeutic challenge. Cellulitis is a clinical diagnosis based on the history of present illness and physical examination and lacks a gold standard for diagnosis. Clinical presentation with acute onset of redness, warmth, swelling, and tenderness and pain is typical. However, cellulitis can be difficult to diagnose due to a number of infectious and non-infectious clinical mimickers such as venous stasis dermatitis, contact dermatitis, eczema, lymphedema, and erythema migrans. Microbiological diagnosis is often unobtainable due to poor sensitivity of culture specimens. The majority of non-purulent, uncomplicated cases of cellulitis are caused by β-hemolytic streptococci or methicillin-sensitive Staphylococcus aureus, and appropriate targeted coverage of this pathogen with oral antibiotics such as penicillin, amoxicillin, and cephalexin is sufficient. Even with rising rates of community-acquired methicillin-resistant Staphylococcus aureus, coverage for non-purulent cellulitis is generally not recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016;316(3):325–37.

    PubMed  Google Scholar 

  2. Zhang M, Markova A, Harp J, Dusza S, Rosenbach M, Kaffenberger BH. Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014. J Am Acad Dermatol. 2019;81(3):740–8.

    PubMed  PubMed Central  Google Scholar 

  3. Peterson RA, Polgreen LA, Cavanaugh JE, Polgreen PM. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017;4(1):ofx008.

    PubMed  PubMed Central  Google Scholar 

  4. Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017;153(2):141–6.

    PubMed  Google Scholar 

  5. Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, et al. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010. BMC Infect Dis. 2015;15:362.

    PubMed  PubMed Central  Google Scholar 

  6. Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025–35.

    PubMed  Google Scholar 

  7. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585–91.

    PubMed  Google Scholar 

  8. Collazos J, de la Fuente B, García A, Gómez H, Menéndez C, Enríquez H, et al. Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS ONE. 2018;13(9): e0204036.

    PubMed  PubMed Central  Google Scholar 

  9. Björnsdóttir S, Gottfredsson M, Thórisdóttir AS, Gunnarsson GB, Ríkardsdóttir H, Kristjánsson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005;41(10):1416–22.

    PubMed  Google Scholar 

  10. Chartier C, Grosshans E. Erysipelas. Int J Dermatol. 1990;29(7):459–67.

    CAS  PubMed  Google Scholar 

  11. Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005;51(5):383–9.

    PubMed  Google Scholar 

  12. Koutkia P, Mylonakis E, Boyce J. Cellulitis: evaluation of possible predisposing factors in hospitalized patients. Diagn Microbiol Infect Dis. 1999;34(4):325–7.

    CAS  PubMed  Google Scholar 

  13. Quirke M, Ayoub F, McCabe A, Boland F, Smith B, O’Sullivan R, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017;177(2):382–94.

    CAS  PubMed  Google Scholar 

  14. McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez JW, Mirzoyev SA, et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin Proc. 2007;82(7):817–21.

    PubMed  Google Scholar 

  15. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318(7198):1591–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Wakkee M, de Vries E, van den Haak P, Nijsten T. Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort. J Am Acad Dermatol. 2011;65(6):1135–44.

    PubMed  Google Scholar 

  17. Norimatsu Y, Ohno Y. Predictors for readmission due to cellulitis among Japanese patients. J Dermatol. 2021;48(5):681–4.

    PubMed  PubMed Central  Google Scholar 

  18. Norimatsu Y, Ohno Y. Sex-based differences in Japanese patients with cellulitis. J Dermatol. 2021;48(11):1797–8.

    PubMed  Google Scholar 

  19. Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Rivas-Carmenado M, et al. Sex differences in hospitalized adult patients with cellulitis: a prospective, multicenter study. Int J Infect Dis. 2021;104:584–91.

    PubMed  Google Scholar 

  20. Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis. 1996;23(5):1091–8.

    CAS  PubMed  Google Scholar 

  21. Veraldi S, Girgenti V, Dassoni F, Gianotti R. Erysipeloid: a review. Clin Exp Dermatol. 2009;34(8):859–62.

    CAS  PubMed  Google Scholar 

  22. Olivieri I, Scarano E, Padula A, Giasi V, Priolo F. Dactylitis, a term for different digit diseases. Scand J Rheumatol. 2006;35(5):333–40.

    CAS  PubMed  Google Scholar 

  23. Hook EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146(2):295–7.

    PubMed  Google Scholar 

  24. Musher DM, Fainstein V, Young EJ. Treatment of cellulitis with ceforanide. Antimicrob Agents Chemother. 1980;17(2):254–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Bruun T, Oppegaard O, Kittang BR, Mylvaganam H, Langeland N, Skrede S. Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study. Open Forum Infect Dis. 2016;3(1):ofv181.

    PubMed  Google Scholar 

  26. Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Menéndez C, et al. Factors associated with sepsis development in 606 Spanish adult patients with cellulitis. BMC Infect Dis. 2020;20(1):211.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Picard D, Klein A, Grigioni S, Joly P. Risk factors for abscess formation in patients with superficial cellulitis (erysipelas) of the leg. Br J Dermatol. 2013;168(4):859–63.

    CAS  PubMed  Google Scholar 

  28. Grada AA, Phillips TJ. Lymphedema: diagnostic workup and management. J Am Acad Dermatol. 2017;77(6):995–1006.

    PubMed  Google Scholar 

  29. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10-52.

    PubMed  Google Scholar 

  30. Carey CF, Dall L. Diagnosis of cellulitis in the immunocompromised host. Can J Infect Dis. 1990;1(4):133–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Dobry AS, et al. Clinical usefulness of imaging and blood cultures in cellulitis evaluation. JAMA Intern Med. 2018;178(7):994–6.

    PubMed  PubMed Central  Google Scholar 

  32. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis. 1999;29(6):1483–8.

    CAS  PubMed  Google Scholar 

  33. Lee CY, Kunin CM, Chang C, Lee SS, Chen YS, Tsai HC. Development of a prediction model for bacteremia in hospitalized adults with cellulitis to aid in the efficient use of blood cultures: a retrospective cohort study. BMC Infect Dis. 2016;16(1):581.

    PubMed  PubMed Central  Google Scholar 

  34. Paolo WF, Poreda AR, Grant W, Scordino D, Wojcik S. Blood culture results do not affect treatment in complicated cellulitis. J Emerg Med. 2013;45(2):163–7.

    PubMed  Google Scholar 

  35. Fabre V, Sharara SL, Salinas AB, Carroll KC, Desai S, Cosgrove SE. Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients. Clin Infect Dis. 2020;71(5):1339–47.

    PubMed  Google Scholar 

  36. van Daalen FV, Kallen MC, van den Bosch CMA, Hulscher MEJL, Geerlings SE, Prins JM. Clinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infections. Eur J Clin Microbiol Infect Dis. 2017;36(10):1853–8.

    PubMed  PubMed Central  Google Scholar 

  37. Raff AB, Weng QY, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study. J Am Acad Dermatol. 2017;76(4):618-25.e2.

    PubMed  Google Scholar 

  38. Krasagakis K, Valachis A, Maniatakis P, Krüger-Krasagakis S, Samonis G, Tosca AD. Analysis of epidemiology, clinical features and management of erysipelas. Int J Dermatol. 2010;49(9):1012–7.

    PubMed  Google Scholar 

  39. Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). 2010;89(4):217–26.

    Google Scholar 

  40. Wells A, Gupta P, Tian F, Adkins E, Kaffenberger B. The effect of implementing teledermatology in patients presenting with cellulitis versus pseudocellulitis in an academic emergency department setting: a pilot study. J Clin Aesthet Dermatol. 2020;13(4):43–4.

    PubMed  PubMed Central  Google Scholar 

  41. Gupta P, Tolliver S, Zhang M, Schumacher E, Kaffenberger BH. Impact of dermatology and teledermatology consultations for patients admitted with cellulitis: a pilot study. J Am Acad Dermatol. 2020;82(2):513–5.

    PubMed  Google Scholar 

  42. Jain SR, Hosseini-Moghaddam SM, Dwek P, Gupta K, Elsayed S, Thompson GW, et al. Infectious diseases specialist management improves outcomes for outpatients diagnosed with cellulitis in the emergency department: a double cohort study. Diagn Microbiol Infect Dis. 2017;87(4):371–5.

    PubMed  Google Scholar 

  43. Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Shah R, et al. Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol. 2018;154(5):529–36.

    PubMed  PubMed Central  Google Scholar 

  44. Ly N, Goldenberg M, Korman AM, Spaccarelli N, Wang H, Chung C, et al. A retrospective study of cellulitis outcomes in Ohio hospitals with or without access to dermatology residency programs. Int J Dermatol. 2021. https://doi.org/10.1111/ijd.15611.

    Article  PubMed  Google Scholar 

  45. Korman AM, Kroshinsky D, Raff AB, Mostaghimi A, Micheletti RG, Rosenbach M, et al. A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology. J Am Acad Dermatol. 2020;82(5):1221–3.

    PubMed  Google Scholar 

  46. Hayeri MR, Ziai P, Shehata ML, Teytelboym OM, Huang BK. Soft-tissue infections and their imaging mimics: from cellulitis to necrotizing fasciitis. Radiographics. 2016;36(6):1888–910.

    PubMed  Google Scholar 

  47. Tayal VS, Hasan N, Norton HJ, Tomaszewski CA. The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department. Acad Emerg Med. 2006;13(4):384–8.

    PubMed  Google Scholar 

  48. Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012;64(2):148–55.

    PubMed  Google Scholar 

  49. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–74.

    CAS  PubMed  Google Scholar 

  50. Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin MR, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013;56(12):1754–62.

    CAS  PubMed  Google Scholar 

  51. Griego RD, Rosen T, Orengo IF, Wolf JE. Dog, cat, and human bites: a review. J Am Acad Dermatol. 1995;33(6):1019–29.

    CAS  PubMed  Google Scholar 

  52. Finkelstein R, Oren I. Soft tissue infections caused by marine bacterial pathogens: epidemiology, diagnosis, and management. Curr Infect Dis Rep. 2011;13(5):470–7.

    PubMed  Google Scholar 

  53. Sayabovorn N, Chongtrakool P, Chayakulkeeree M. Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review. BMC Infect Dis. 2021;21(1):27.

    PubMed  PubMed Central  Google Scholar 

  54. Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2018;32(1):e00069-e118.

    PubMed  PubMed Central  Google Scholar 

  55. Maraki S, Christidou A, Anastasaki M, Scoulica E. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections. Infect Dis (Lond). 2016;48(3):171–6.

    CAS  PubMed  Google Scholar 

  56. Flahou B, Haesebrouck F, Smet A, Yonezawa H, Osaki T, Kamiya S. Gastric and enterohepatic non-Helicobacter pylori Helicobacters. Helicobacter. 2013;18(Suppl 1):66–72.

    PubMed  Google Scholar 

  57. Shimizu S, Shimizu H. Cutaneous manifestations of Helicobacter cinaedi: a review. Br J Dermatol. 2016;175(1):62–8.

    CAS  PubMed  Google Scholar 

  58. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10(Suppl 1):67–75.

    PubMed  Google Scholar 

  59. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore). 1997;76(1):30–41.

    CAS  Google Scholar 

  60. Thompson DK, Sharkady SM. Expanding spectrum of opportunistic Cedecea infections: current clinical status and multidrug resistance. Int J Infect Dis. 2020;100:461–9.

    CAS  PubMed  Google Scholar 

  61. Ekpanyapong S, Reddy KR. Infections in cirrhosis. Curr Treat Options Gastroenterol. 2019;17(2):254–70.

    PubMed  PubMed Central  Google Scholar 

  62. Falagas ME, Kastoris AC, Vouloumanou EK, Dimopoulos G. Community-acquired Stenotrophomonas maltophilia infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2009;28(7):719–30.

    CAS  PubMed  Google Scholar 

  63. Khan T, Martin DH. Streptococcus pneumoniae soft tissue infections in human immunodeficiency virus. Am J Med Sci. 2011;342(3):235–8.

    PubMed  Google Scholar 

  64. Paterson DL, Gruttadauria S, Lauro A, Scott V, Marino IR. Spontaneous gram-negative cellulitis in a liver transplant recipient. Infection. 2001;29(6):345–7.

    CAS  PubMed  Google Scholar 

  65. Yoon TY, Jung SK, Chang SH. Cellulitis due to Escherichia coli in three immunocompromised subjects. Br J Dermatol. 1998;139(5):885–8.

    CAS  PubMed  Google Scholar 

  66. Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, et al. Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis. 1998;27(2):252–5.

    CAS  PubMed  Google Scholar 

  67. Chen YS, Liu YC, Yen MY, Wang JH, Wann SR, Cheng DL. Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis. 1997;25(2):225–9.

    CAS  PubMed  Google Scholar 

  68. Crowe HM, Levitz RE. Invasive Haemophilus influenzae disease in adults. Arch Intern Med. 1987;147(2):241–4.

    CAS  PubMed  Google Scholar 

  69. Beckman EN, Leonard GL, Castillo LE, Genre CF, Pankey GA. Histopathology of marine vibrio wound infections. Am J Clin Pathol. 1981;76(6):765–72.

    CAS  PubMed  Google Scholar 

  70. Hurwitz RM, Leaming RD, Horine RK. Necrotic cellulitis. A localized form of septic vasculitis. Arch Dermatol. 1984;120(1):87–92.

    CAS  PubMed  Google Scholar 

  71. Musher DM. Cutaneous and soft-tissue manifestations of sepsis due to Gram-negative enteric bacilli. Rev Infect Dis. 1980;2(6):854–66.

    CAS  PubMed  Google Scholar 

  72. Kolivras A, Provost P, Thompson CT. Erysipelas-like erythema of familial Mediterranean fever syndrome: a case report with emphasis on histopathologic diagnostic clues. J Cutan Pathol. 2013;40(6):585–90.

    PubMed  Google Scholar 

  73. Levell NJ, Wingfield CG, Garioch JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011;164(6):1326–8.

    CAS  PubMed  Google Scholar 

  74. Strazzula L, Cotliar J, Fox LP, Hughey L, Shinkai K, Gee SN, et al. Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: a multi-institutional analysis. J Am Acad Dermatol. 2015;73(1):70–5.

    PubMed  Google Scholar 

  75. Sundaresan S, Migden MR, Silapunt S. Stasis dermatitis: pathophysiology, evaluation, and management. Am J Clin Dermatol. 2017;18(3):383–90.

    PubMed  Google Scholar 

  76. Thornton NJ, Gibson BR, Ferry AM. Contact dermatitis and medical adhesives: a review. Cureus. 2021;13(3): e14090.

    PubMed  PubMed Central  Google Scholar 

  77. Johansen JD, Werfel T. Highlights in allergic contact dermatitis 2018/2019. Curr Opin Allergy Clin Immunol. 2019;19(4):334–40.

    PubMed  Google Scholar 

  78. Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96(10):731–8.

    CAS  PubMed  Google Scholar 

  79. Marchionne EM, McCalmont TH, Pincus LB, LeBoit PE, Fox LP. Acute inflammatory edema: a mimicker of cellulitis in critically ill patients. J Am Acad Dermatol. 2019;81(4):931–6.

    PubMed  Google Scholar 

  80. Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease. Am J Med. 1995;98(4A):15S-23S (Discussion 23S-24S).

    CAS  PubMed  Google Scholar 

  81. Gunderson CG, Chang JJ. Risk of deep vein thrombosis in patients with cellulitis and erysipelas: a systematic review and meta-analysis. Thromb Res. 2013;132(3):336–40.

    CAS  PubMed  Google Scholar 

  82. Stevens DL, Bryant AE, Goldstein EJ. Necrotizing soft tissue infections. Infect Dis Clin N Am. 2021;35(1):135–55.

    Google Scholar 

  83. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221(5):558–63 (Discussion 63-5).

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Wall DB, Klein SR, Black S, de Virgilio C. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000;191(3):227–31.

    CAS  PubMed  Google Scholar 

  85. Bechar J, Sepehripour S, Hardwicke J, Filobbos G. Laboratory risk indicator for necrotising fasciitis (LRINEC) score for the assessment of early necrotising fasciitis: a systematic review of the literature. Ann R Coll Surg Engl. 2017;99(5):341–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377(23):2253–65.

    PubMed  Google Scholar 

  87. Cribb BI, Wang MTM, Kulasegaran S, Gamble GD, MacCormick AD. The SIARI Score: a novel decision support tool outperforms LRINEC Score in necrotizing fasciitis. World J Surg. 2019;43(10):2393–400.

    PubMed  Google Scholar 

  88. Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a clinical score for necrotizing fasciitis: ‘Pain Out of Proportion’ and high CRP levels aid the diagnosis. PLoS ONE. 2015;10(7): e0132775.

    PubMed  PubMed Central  Google Scholar 

  89. Ramchandani M, Kong M, Tronstein E, Selke S, Mikhaylova A, Magaret A, et al. Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults. Sex Transm Dis. 2016;43(12):756–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Schmutzhard J, Riedel HM, Wirgart BZ, Grillner L. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol. 2004;29(2):120–6.

    CAS  PubMed  Google Scholar 

  91. von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31(4):535–56 (Quiz 57-60).

    PubMed  Google Scholar 

  92. StatPearls. Treasure Island, FL; StatPearls; 2021.

  93. Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019;210(11):516–24.

    PubMed  Google Scholar 

  94. Cox SE, Cruz PD. A spectrum of inflammatory metastasis to skin via lymphatics: three cases of carcinoma erysipeloides. J Am Acad Dermatol. 1994;30(2 Pt 2):304–7.

    CAS  PubMed  Google Scholar 

  95. Korkij W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol. 1984;120(4):520–4.

    CAS  PubMed  Google Scholar 

  96. Obaitan I, Dwyer R, Lipworth AD, Kupper TS, Camargo CA, Hooper DC, et al. Failure of antibiotics in cellulitis trials: a systematic review and meta-analysis. Am J Emerg Med. 2016;34(8):1645–52.

    PubMed  Google Scholar 

  97. Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372(12):1093–103.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Williams OM, Brindle R. Antibiotic route and duration of therapy for cellulitis: data extracted from a multi-center clinical trial. Int J Antimicrob Agents. 2020;56(3): 106076.

    CAS  PubMed  Google Scholar 

  99. Madaras-Kelly KJ, Remington RE, Oliphant CM, Sloan KL, Bearden DT. Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis. Am J Med. 2008;121(5):419–25.

    CAS  PubMed  Google Scholar 

  100. Khawcharoenporn T, Tice A. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis. Am J Med. 2010;123(10):942–50.

    PubMed  Google Scholar 

  101. Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, et al. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51(7):2628–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  102. Livermore DM, Pearson A. Antibiotic resistance: location, location, location. Clin Microbiol Infect. 2007;13(Suppl 2):7–16.

    CAS  PubMed  Google Scholar 

  103. Cross ELA, Jordan H, Godfrey R, Onakpoya IJ, Shears A, Fidler K, et al. Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020;81(4):521–31.

    CAS  PubMed  Google Scholar 

  104. Jenkins TC, Knepper BC, Sabel AL, Sarcone EE, Long JA, Haukoos JS, et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch Intern Med. 2011;171(12):1072–9.

    PubMed  Google Scholar 

  105. Talan DA, Mower WR, Lovecchio FA, Rothman RE, Steele MT, Keyloun K, et al. Pathway with single-dose long-acting intravenous antibiotic reduces emergency department hospitalizations of patients with skin infections. Acad Emerg Med. 2021;28(10):1108–17.

    PubMed  PubMed Central  Google Scholar 

  106. Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010;16(6):729–34.

    CAS  PubMed  Google Scholar 

  107. Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol. 2008;158(6):1350–3.

    CAS  PubMed  Google Scholar 

  108. Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017;6(6): CD009758.

    PubMed  Google Scholar 

  109. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol. 2015;151(11):1187–93.

    PubMed  Google Scholar 

  110. Mihara M, Hara H, Furniss D, Narushima M, Iida T, Kikuchi K, et al. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema. Br J Surg. 2014;101(11):1391–6.

    CAS  PubMed  Google Scholar 

  111. Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. Compression therapy to prevent recurrent cellulitis of the leg. N Engl J Med. 2020;383(7):630–9.

    CAS  PubMed  Google Scholar 

  112. Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013;368(18):1695–703.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Catherine G. Chung.

Ethics declarations

Funding

No sources of funding were used to assist in the preparation of this article.

Conflicts of Interest

Michelle Boettler, Benjamin Kaffenberger and Catherine Chung state no conflicts of interest.

Ethics Approval

Not applicable.

Informed Consent

Not applicable.

Consent for publication

Not applicable.

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Code availability

Not applicable.

Author Contributions

All authors contributed to the review conception and design. The first draft of the manuscript was written by Michelle Boettler and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boettler, M.A., Kaffenberger, B.H. & Chung, C.G. Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis. Am J Clin Dermatol 23, 153–165 (2022). https://doi.org/10.1007/s40257-021-00659-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-021-00659-8

Navigation